Literature DB >> 2483763

Aprotinin (trasylol) is a competitive inhibitor of activated protein C.

F España1, A Estelles, J H Griffin, J Aznar, J Gilabert.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2483763     DOI： 10.1016/0049-3848(89)90292-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  3 in total

Review 1.  Aprotinin and major orthopedic surgery.

Authors:  Charles Marc Samama
Journal:  Eur Spine J       Date:  2004-07-02       Impact factor: 3.134

Review 2.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

Review 3.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.